• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Neoadjuvant Strategies: Locally Advanced Rectal Cancer.新辅助治疗策略:局部晚期直肠癌
Clin Colon Rectal Surg. 2017 Nov;30(5):383-386. doi: 10.1055/s-0037-1606372. Epub 2017 Nov 27.
2
Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.血小板计数升高是接受新辅助放化疗的局部晚期直肠癌的阴性预测和预后标志物:一项针对 965 例患者的回顾性多机构研究。
BMC Cancer. 2018 Nov 12;18(1):1094. doi: 10.1186/s12885-018-5022-1.
3
Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer.新辅助放化疗与直肠癌的病理完全缓解。
Gastroenterol Rep (Oxf). 2015 Nov;3(4):277-88. doi: 10.1093/gastro/gov039. Epub 2015 Aug 19.
4
[Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].巩固性新辅助治疗或全新辅助治疗后低位直肠癌的保直肠手术:初步报告
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):281-288. doi: 10.3760/cma.j.cn.441530-20200228-00096.
5
Clinical outcome of neoadjuvant chemoradiation in locally advanced rectal cancer at a tertiary hospital.三级医院局部晚期直肠癌新辅助放化疗的临床结局
Hong Kong Med J. 2016 Dec;22(6):546-55. doi: 10.12809/hkmj154788. Epub 2016 Oct 31.
6
[Controversies and progress in adjuvant chemotherapy for patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy].接受新辅助放化疗的局部晚期直肠癌患者辅助化疗的争议与进展
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jun 25;22(6):594-596. doi: 10.3760/cma.j.issn.1671-0274.2019.06.015.
7
Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer.新辅助放化疗与局部晚期直肠癌患者生存的关系。
Colorectal Dis. 2017 Dec;19(12):1058-1066. doi: 10.1111/codi.13754.
8
Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).韩国结直肠外科学会(KSCP)新辅助同期放化疗后局部中低位进展期直肠癌巩固化疗的临床试验:一项多中心、随机对照试验(KONCLUDE)。
BMC Cancer. 2018 May 8;18(1):538. doi: 10.1186/s12885-018-4466-7.
9
Oncologic outcomes of neoadjuvant chemoradiation for locally advanced rectal cancer: a single-institution experience.局部进展期直肠癌新辅助放化疗的肿瘤学结局:单机构经验。
Ann Acad Med Singap. 2014 Dec;43(12):569-75.
10
Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.黏液组织学对直肠癌中基于卡培他滨的新辅助放化疗后病理完全缓解率的预测意义:一项对比研究
J Gastrointest Cancer. 2019 Dec;50(4):716-722. doi: 10.1007/s12029-018-0136-x.

引用本文的文献

1
Predictors for temporary stomas non-closure among non-metastatic rectal cancer patients undergoing curative resection: a retrospective analysis.接受根治性切除术的非转移性直肠癌患者临时造口无法关闭的预测因素:一项回顾性分析。
World J Surg Oncol. 2024 May 7;22(1):124. doi: 10.1186/s12957-024-03403-8.
2
MRI-based pre-Radiomics and delta-Radiomics models accurately predict the post-treatment response of rectal adenocarcinoma to neoadjuvant chemoradiotherapy.基于磁共振成像(MRI)的放射组学前期模型和增量放射组学模型能够准确预测直肠腺癌对新辅助放化疗的治疗后反应。
Front Oncol. 2023 Feb 22;13:1133008. doi: 10.3389/fonc.2023.1133008. eCollection 2023.
3
Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer.局部进展期结肠癌新辅助同期放化疗的再评价。
PLoS One. 2021 Nov 2;16(11):e0259460. doi: 10.1371/journal.pone.0259460. eCollection 2021.
4
Mutated DNA Damage Repair Pathways Are Prognostic and Chemosensitivity Markers for Resected Colorectal Cancer Liver Metastases.突变的DNA损伤修复通路是切除的结直肠癌肝转移的预后和化疗敏感性标志物。
Front Oncol. 2021 Mar 31;11:643375. doi: 10.3389/fonc.2021.643375. eCollection 2021.
5
Overall Survival Benefit in Rectal Cancer After Neoadjuvant Radiotherapy and Adjuvant Chemotherapy: A Propensity-Matched Population-Based Study.新辅助放疗和辅助化疗后直肠癌的总生存获益:一项基于倾向评分匹配的人群研究
Front Oncol. 2020 Dec 9;10:584835. doi: 10.3389/fonc.2020.584835. eCollection 2020.
6
Gd-EOB-DTPA-enhanced MR findings in chemotherapy-induced sinusoidal obstruction syndrome in colorectal liver metastases.结直肠癌肝转移化疗诱导的窦状隙阻塞综合征中钆塞酸二钠增强磁共振的表现。
J Int Med Res. 2020 Jun;48(6):300060520926031. doi: 10.1177/0300060520926031.
7
Intraoperative intraperitoneal chemotherapy increases the incidence of anastomotic leakage after anterior resection of rectal tumors.术中腹腔内化疗会增加直肠肿瘤前切除术术后吻合口漏的发生率。
World J Gastrointest Oncol. 2019 Jul 15;11(7):538-550. doi: 10.4251/wjgo.v11.i7.538.

本文引用的文献

1
Short Course Radiation in the Treatment of Localized Rectal Cancer: A Systematic Review and Meta-Analysis.短程放疗治疗局限性直肠癌:一项系统评价与荟萃分析
Sci Rep. 2015 Jun 9;5:10953. doi: 10.1038/srep10953.
2
Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.术前(放)化疗和全直肠系膜切除术治疗的直肠癌患者的辅助化疗:荷兰结直肠肿瘤学组(DCCG)的一项随机 III 期试验。
Ann Oncol. 2015 Apr;26(4):696-701. doi: 10.1093/annonc/mdu560. Epub 2014 Dec 5.
3
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.奥沙利铂、氟尿嘧啶和亚叶酸钙与氟尿嘧啶和亚叶酸钙作为术前放化疗后局部进展期直肠癌的辅助化疗(ADORE):一项开放标签、多中心、2 期、随机对照临床试验。
Lancet Oncol. 2014 Oct;15(11):1245-53. doi: 10.1016/S1470-2045(14)70377-8. Epub 2014 Sep 4.
4
Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control.文献标题:新辅助放化疗后局部进展期直肠癌随机 III 期临床试验结果,术后辅助卡培他滨加奥沙利铂(XELOX)与对照组比较 **解析**:这是一个医学文献的标题,其中包含了一些医学术语。在翻译时,需要注意保留关键词,如“Chronicle”(文献标题)、“randomised phase III trial”(随机 III 期临床试验)、“locally advanced rectal cancer”(局部进展期直肠癌)、“neoadjuvant chemoradiation”(新辅助放化疗)、“adjuvant capecitabine plus oxaliplatin”(术后辅助卡培他滨加奥沙利铂)、“XELOX”(药物名称)等。同时,还需要注意一些词汇的翻译,如“randomise”(随机化)、“postoperative”(术后的)等。
Ann Oncol. 2014 Jul;25(7):1356-1362. doi: 10.1093/annonc/mdu147. Epub 2014 Apr 8.
5
The magnetic resonance imaging-based approach for identification of high-risk patients with upper rectal cancer.基于磁共振成像的高位直肠癌高危患者识别方法。
Ann Surg. 2014 Aug;260(2):293-8. doi: 10.1097/SLA.0000000000000503.
6
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.术前放化疗后氟尿嘧啶为基础的辅助化疗治疗直肠癌:EORTC 22921 随机研究的长期结果。
Lancet Oncol. 2014 Feb;15(2):184-90. doi: 10.1016/S1470-2045(13)70599-0. Epub 2014 Jan 17.
7
Selecting patients with locally advanced rectal cancer for neoadjuvant treatment strategies.选择局部进展期直肠癌患者进行新辅助治疗策略。
Oncologist. 2013;18(7):833-42. doi: 10.1634/theoncologist.2013-0022. Epub 2013 Jul 2.
8
Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.T3 期直肠癌患者短程放疗与长程放化疗局部复发率比较的随机试验:跨塔斯曼肿瘤放疗组试验 01.04.
J Clin Oncol. 2012 Nov 1;30(31):3827-33. doi: 10.1200/JCO.2012.42.9597. Epub 2012 Sep 24.
9
Postoperative adjuvant chemotherapy in rectal cancer operated for cure.针对接受根治性手术的直肠癌患者的术后辅助化疗。
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD004078. doi: 10.1002/14651858.CD004078.pub2.
10
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.术前放疗联合全直肠系膜切除术治疗可切除直肠癌:多中心随机对照 TME 试验的 12 年随访结果。
Lancet Oncol. 2011 Jun;12(6):575-82. doi: 10.1016/S1470-2045(11)70097-3. Epub 2011 May 17.

新辅助治疗策略:局部晚期直肠癌

Neoadjuvant Strategies: Locally Advanced Rectal Cancer.

作者信息

Ahmed Shahab, Eng Cathy

机构信息

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

出版信息

Clin Colon Rectal Surg. 2017 Nov;30(5):383-386. doi: 10.1055/s-0037-1606372. Epub 2017 Nov 27.

DOI:10.1055/s-0037-1606372
PMID:29184474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5703667/
Abstract

Colorectal cancer is one of the major leading causes of death in both men and women. The successful management of colon or rectal cancer demands a multidisciplinary approach. In the last few years, significant improvement has been noticed in the management of localized rectal cancer to reduce local recurrence and obtain complete pathological response following appropriate surgical steps, if necessary. Implementation of neoadjuvant therapy not only enhances disease control, it may also ensure sphincter preserving procedures or organ-preserving options. This article principally concentrates on the current neoadjuvant treatment for locally advanced rectal cancer and the prognostic outcomes of such therapy, including a discussion on the historical perspective.

摘要

结直肠癌是男性和女性主要的致死原因之一。结肠癌或直肠癌的成功治疗需要多学科方法。在过去几年中,局部直肠癌的治疗有了显著改善,以减少局部复发,并在必要时通过适当的手术步骤获得完全的病理缓解。新辅助治疗的实施不仅能加强疾病控制,还可能确保保留括约肌的手术或保留器官的选择。本文主要关注局部晚期直肠癌的当前新辅助治疗及其预后结果,包括对历史观点的讨论。